Abstract
Proteus mirabilis is an opportunistic pathogen often associated with a variety of human infections acquired both in the community and in hospitals. In this context, the present work aimed to evaluate the genotypic and phenotypic characteristics of the virulence factors and antimicrobial resistance determinants of 32 P. mirabilis strains isolated from chicken carcasses in a poultry slaughterhouse in the north of the state of Paraná, Brazil, in order to assess a potential zoonotic risk. The isolates presented a variety of virulence genes that contribute to the development of infection in humans. The mrpA, pmfA, atfA (fimbriae), ireA (siderophores receptor), zapA, ptA (Proteases), and hpmA (hemolysin) genes were found in 32 (100%) isolates and ucaA (fimbriae) in 16 (50%). All isolates showed aggregative adherence in HEp-2 cells and formed biofilms. Of all strains, 27 (84.38%) showed cytotoxic effects in Vero cells. Antimicrobial susceptibility was tested using 20 antimicrobials, in which 25 (78.13%) strains were considered multidrug-resistant. The presence of blaESBL and blaampC genes conferring resistance to β-lactams and qnr to quinolones were also detected in the isolates after presumption in the phenotypic test, in which 7 (21.88%) isolates contained the CTX-M-2 group, 11 (34.38%) contained CIT group and 19 (59.38%) contained qnrD. Therefore, chicken carcasses contaminated with P. mirabilis may pose a health risk to the consumer, as these isolates have a variety of virulence and antimicrobial resistance characteristics that can be found in P. mirabilis strains isolated from human infections.
Keywords: Foodborne, Poultry, Public health, Multidrug-resistant, ESBL, AmpC
Introduction
The Brazilian poultry industry has been outstanding in both the national and international markets, with Brazil being considered the second largest producer and leader in the world export of chicken meat. The southern region of Brazil is responsible for the majority of the production of broilers, with Paraná state being the largest national producer and accounting for more than 35% of the exports of all chicken meat produced in the country [1].
In view of the commercialization and relevance of the product throughout the world, it is essential to ensure the microbiological quality of poultry meat. In fact, all processing steps during and after the chicken slaughter can contaminate the meat with bacteria present in the avian microbiota and in the slaughterhouse, especially in equipment that helps in the handling of carcasses, cuts, and by-products [2].
The fact that Proteus spp. is isolated from chicken feces along with other enteric bacteria, such as Escherichia coli, indicates its function as a component of the normal intestinal microbiota [3]. This facilitates the transfer of these bacteria to the slaughter line and cross-contamination, especially in the carcass evisceration process [4].
Some of these bacterial contaminants may remain after carcass processing and survive storage. It is therefore essential for the consumer to be aware that chicken meat can be a source of transmission of microorganisms. Therefore, in order to avoid possible cross-contamination, it is essential for taking care of the disinfection of the handling tools after the preparation of the meat [4].
The isolation of P. mirabilis from food products is documented in some studies, especially in those of animal origin, such as chicken meat, and some of these isolates are considered multidrug-resistant (MDR) [5, 6]. Bacterial resistance is a global public health threat and the excessive use of antimicrobials in poultry accelerates this phenomenon [7]. The problem is predicted to increase considerably in the coming years due to the intensification of the production of foods from animal origin and the non-rational use of antimicrobials [8].
P. mirabilis is a Gram-negative bacterium widely found in the environment and isolated from the intestinal tract of humans and other animals [3]. Although it is considered a commensal, the reports of occasional cases of infection and the description of nosocomial outbreaks point to its opportunistic pathogenic potential. Urinary tract infection (UTI) stands out as the most prevalent P. mirabilis infection, which has the capacity to cause other diseases in humans [9].
Several virulence factors may be associated with the pathogenicity of P. mirabilis in humans, such as fimbriae mannose-resistant Proteus-like (MR/P), Proteus mirabilis fimbriae (PMF), and uroepithelial cell adhesin (UCA), which allow bacterial-cell adhesion to host cells [9], PtA and ZapA proteases that degrade structural proteins and the immune system, respectively [10, 11], hemolysins HpmA and HlyA, considered toxins for host cells and involved in colonization of the urinary tract [12, 13], siderophores receptor IreA, considered of great importance in the acquisition of Fe+3 of the host [14]. In addition, adhesion capacity, formation of biofilms, and cytotoxicity are also important in the infectious process [9, 15].
Additionally, P. mirabilis has been associated with foodborne disease, despite their primary pathogenic role has not been confirmed [16–18], and may be a public health threat to society due to its strong association with a variety of human infectious diseases [19]. Therefore, more research is indicated to discuss and elucidate the zoonotic potential of P. mirabilis.
The present study aimed to characterize P. mirabilis strains isolated from chicken carcasses in the slaughter line, as well as the genotypic and phenotypic characteristics of virulence factors and antimicrobial resistance. To our knowledge, this is the first study from Brazil that explores the general virulence and antimicrobial resistance characteristics of P. mirabilis strains isolated from carcasses of broiler chickens, in order to explore their zoonotic potential.
Materials and methods
Food samples
A total of 42 chicken carcasses were evaluated through sterile swabs scrubbed on the surface of the thighs and abdomen of non-eviscerated chickens in two time periods separated by a 15-day interval. All carcasses were randomly selected in the slaughter line during a sanitary inspection of a poultry slaughterhouse in the north of Paraná, Brazil. The isolates were collected using sterile Swabs and the collected material was transported in Cary-Blair medium (Difco™, USA).
Bacterial isolation and identification
The collected material was transferred to Brain Heart Infusion broth (Difco™, USA) and cultured at 37 °C for 24 h. After bacterial growth, the samples were plated on MacConkey Agar plates (Difco™, USA), and incubated at 37 °C for 24 h. Suspected colonies were confirmed to be P. mirabilis with the biochemical tests EPM, MILi (PROBAC™, BR), and Simmons citrate (Difco™, USA).
Detection of virulence genes
We investigated nine genes associated with the virulence of P. mirabilis in humans. The selected genes included ireA (siderophore receptor), mrpA, ucaA, pmfA, atfA (fimbriae), ptA and zapA (proteases), and hmpA and hlyA (hemolysins), as shown in Table 1. The bacterial DNA was obtained by the boiling extraction method. The polymerase chain reaction (PCR) was performed on a GeneAmp PCR System 9700 thermal cycler (Applied Biosystems™) containing the final volume of 25 μL, composed of 2 mM MgCl2 (Invitrogen™), 10× buffer (Invitrogen™), 0.2 mM dNTPs (Invitrogen™), 20 pmol Primer Forward, 20 pmol Primer Reverse (Invitrogen™), 1.25 U Taq DNA polymerase (Invitrogen®), bacterial DNA, and Milli-Q ultrapure water (Millipore™). PCR products were size separated by gel electrophoresis on a 2% agarose gel stained with SYBR SAFE (Invitrogen™) and emerged in TBE buffer (89 mM Tris base, 89 mM Boric Acid, 2 mM EDTA, pH 8.3). The molecular marker used was a 1 Kb Ladder (Invitrogen™). The amplicons were observed in a transilluminator with ultraviolet light (Vilbert Loumart™). The primers designed in this study were based on the complete genome sequence of the P. mirabilis strain HI4320 [22] and were used in the PCR following the conditions: 95 °C/5 min, 30 cycles of 95 °C/1 min, hybridization temperature/1 min, 72 °C/1 min, and final extension at 72 °C/7 min. The strain P. mirabilis HI4320 was used as positive control [22] and the reaction without DNA as a negative control.
Table 1.
Genes associated with virulence of P. mirabilis screened by PCR
| Genes | Primers sequences (5′➔3′) | (bp) | Hybridization temperatures | References |
|---|---|---|---|---|
| ireA |
(F) ACTACGATAACGAGCGCCAG (R) GCCCTAACTGGGGGAATACG |
681 | 60 °C | This study |
| mrpA |
(F) GAGCCATTCAATTAGGAATAATCCA (R) AGCTCTGTACTTCCTTGTACAGA |
648 | 58 °C | [20] |
| ucaA |
(F) GCTTTTACATCCCCAGCGGT (R) GCTGCATTTGCTGGCTCATC |
476 | 60 °C | This study |
| pmfA |
(F) CAAATTAATCTAGAACCACTC (R) ATTATAGAGGATCCCTTGAAGGTA |
617 | 54 °C | This study |
| atfA |
(F) CATAATTTCTAGACCTGCCCTAGCA (R) CTGCTTGGATCCGTAATTTTTAACG |
382 | 50 °C | [21] |
| ptA |
(F) CCACTGCGATTATCCGCTCT (R) ATCGGCAGAAGTGACAAGCA |
686 | 60 °C | This study |
| zapA |
(F) TATCGTCTCCTTCGCCTCCA (R) TGGCGCAAATACGACTACCA |
332 | 59 °C | This study |
| hpmA |
(F) GTTGAGGGGCGTTATCAAGAGTC (R) GATACTGTTTTGCCCTTTTGTGC |
709 | 55 °C | [12] |
| hlyA |
(F) AACAAGGATAAGCACTGTTCTGGCT (R) ACCATATAAGCGGTCATTCCCGTCA |
1177 | 63 °C | [12] |
bp base pairs
Adherence in HEp-2 cells
The adherence capacity of the isolates of P. mirabilis to human larynx carcinoma (HEp-2) cells was analyzed as previously described [23]. Bacterial-cell interactions were assayed for 6 h. HEp-2 cells were grown in 24-well plates with 13 mm coverslips containing 1 mL DMEM (Dulbecco’s Modified Eagle Medium). After the formation of a HEp-2 cell monolayer, the medium was discarded and the plates were washed three times with phosphate-buffered saline (PBS), containing 9.7 mM Na2HPO4, 1.25 mM KH2PO4, 137.93 mM NaCl, and 2.68 mM KCl. Next, 1 mL DMEM without antibiotics supplemented with 2% fetal bovine serum (FBS) was added to each well. Subsequently, a 40 μL aliquot of the bacterial culture overnight in tryptic soy broth (TSB) was added to each well and the plates were incubated for 3 h at 37 °C. After this step, the wells were washed five times with 1 mL sterile PBS to remove non-adhering bacteria. Once more, 1 mL of DMEM with 2% SFB was added to the wells and incubated for an additional 3 h at 37 °C. At the end of the 6 h period, the wells were washed five times with PBS, then the coverslips were fixed with 100% methanol and stained with May-Grünwald for 5 min and Giemsa for 20 min. The coverslips were observed under a light microscope at 1000x magnification. Cells incubated without bacteria were used as negative control and E. coli E2348/69 [24], 042 [25] and C1845 [26] as positive controls for the patterns of localized, aggregative and diffuse adhesion, respectively.
Cytotoxicity in Vero cell cultures
All 32 bacterial isolates were tested in Vero cells (African green monkey kidney) to evaluate cytotoxic capacity as demonstrated [27], with modifications. The isolates were cultured in 3 mL TSB broth at 37 °C for 18 h under shaking at 180 rpm. After bacterial growth, the samples were centrifuged at 13000 g for 10 min. The supernatants were collected and filtered through a syringe filter with a PVDF membrane (Durapore™) with 0.22-μm pore size and 47-mm diameter. Filtered supernatants were added in four repetitions each to a 96-well polystyrene plate at a dilution of 1:10 and subsequently incubated for 72 h at 37 °C and 5% CO2.
The cytotoxicity of the isolates was quantified measuring the metabolic activity of Vero cells with the MTT (3-[4,5-dimethyl-thiazol-2-yl]-2,5-diphenyl-tetrazolium bromide) assay [28]. Cells without bacterial supernatant were used as a negative control and E. coli O157:H7 (EDL933) was used as a positive control for cytotoxicity in Vero cells [29]. The isolate was considered highly cytotoxic when 50% or more of cell death were measured in comparison with the negative control.
Biofilm formation
The biofilm assay was performed on 96-well polystyrene plates as previously described [30] using crystal violet. E. coli 042 (O44:H18) [25] was used as positive control for biofilm formation and TSB Broth (Difco™) only was used as negative control. The absorbance readings (A) were performed in a spectrophotometer at a wavelength of 570 nm. The threshold value of the absorbance (T) confirmed the biofilm formation and was defined as the sum of the arithmetic mean of the negative control (nc) and three times the standard deviation (δ), according to the formula (T = xnc + 3δ).
Susceptibility to antimicrobials
The resistance of all 32 isolates was evaluated with the disc diffusion method in Mueller-Hinton agar, using the antimicrobials as recommended by the Clinical and Laboratory Standards Institute [31]. The antimicrobials (Oxoid™) used were Ampicillin (AMP) 10 μg, amoxicillin + clavulanate (AMC) 20/10 μg, cephalotin (CFL) 30 μg, cefoxitin (CFO) 30 μg, ceftazidime (CAZ) 30 μg, Ceftriaxone (CRO) 30 μg, cefotaxime (CTX) 30 μg, cefepime (CPM) 30 μg, nalidixic Acid (NAL) 30 μg, norfloxacin (NOR) 10 μg, ciprofloxacin (CIP) 5 μg, trimethoprim-sulfamethoxazole (SUT) 1.25/23.75 μg, aztreonam (ATM) 30 μg, chloramphenicol (CLO) 30 μg, gentamicin (GEN) 10 μg, amikacin (AMI) 30 μg, ertapenem (ETP) 10 μg, and imipenem (IPM) 10 μg. Additionally, ceftiofur (CTF) 30 μg, enrofloxacin (ENO) 5 μg were used [32]. The isolate was considered multidrug-resistant when it exhibited resistance to three or more classes of antimicrobials [33]. E. coli ATCC® 25922™ was used for quality control purposes.
Detection of resistance genes
The detection of resistance genes was performed by PCR assay. All isolates that exhibited resistance to cephalosporins in the phenotypic assay were screened for the presence of ESBL-encoding groups of the type CTX-M 1, 2, 8, 9, and 25 [34], TEM and SHV [35], as well as the six plasmid-mediated AmpC-specific families, MOX, FOX, EBC, ACC, DHA, and CIT [36]. The quinolone resistance genes qnrA, qnrB, qnrS [37], and qnrD [38] were also investigated in isolates that exhibited resistance to quinolones in the phenotypic assay.
Results
Genotypic and phenotypic profile of virulence
From a total of 42 chicken carcasses evaluated, 32 were positive for the presence of P. mirabilis. Only one strain was isolated from each positive carcass, totalizing 32 strains. The bacterial isolates studied presented a variety of virulence genes that enable and contribute to the development of infection in humans. The mrpA, pmfA, atfA (fimbriae), zapA, ptA (proteases), hpmA (hemolysin), and ireA (siderophore receptor) genes were detected in all isolates, evidencing a high prevalence of these genes in P. mirabilis isolated from chicken carcasses. The gene ucaA (fimbriae) was the least prevalent among fimbrial genes, being found in 16 (50%) isolates. The hlyA (hemolysin) gene was not detected in any isolate.
The phenotypic characterization of the virulence factors investigated in our study showed that all 32 (100%) isolates expressed a pattern of aggregative adhesion to HEp-2 cells cultures (Fig. 1) and showed a capacity for biofilm formation in polystyrene plates, in which 17 isolates (53.12%) formed a strong biofilm and 15 (46.88%) a very strong biofilm (Fig. 2). In addition to these phenotypic characteristics of virulence, a highly cytotoxic effect on Vero cell culture was measured for a total number of 27 (84.38%) isolates. The genotypic and phenotypic profile of the virulence factors of these strains is presented in Table 2.
Fig. 1.

Aggregative adhesion pattern exhibited by P. mirabilis strain isolated from chicken carcass (magnification × 1000)
Fig. 2.
Intensity of P. mirabilis biofilm isolated from chicken carcasses
Table 2.
Genotypic and phenotypic characteristics of virulence and antimicrobial resistance of P. mirabilis isolated from chicken carcasses
| Strains | Virulence genes | A.A | C.V.C | Biofilm | Phenotypic profile of resistance | Resistance genes |
|---|---|---|---|---|---|---|
| LB UEL – A01 | mrpA, pmfA, atfA, ireA, ptA, zapA, hpmA | + | + | + | AMP, CTF, AMC, CFL, CFO, CAZ, CTX, NAL, ENO, SUT | CIT, qnrD |
| LB UEL – A02 | mrpA, pmfA, atfA, ireA, ptA, zapA, hpmA | + | − | + | AMP, CTF, AMC, CFL, CFO, CAZ, CRO, CTX, CPM, NAL, ENO, SUT | CIT, qnrD |
| LB UEL – A03 | mrpA, ucaA, pmfA, atfA, ireA, ptA, zapA, hpmA | + | − | + | AMP, AMC, CFL, CFO, CAZ, CTX, NAL, SUT, GEN | CIT |
| LB UEL – A04 | mrpA, pmfA, atfA, ireA, ptA, zapA, hpmA | + | + | + | AMP, CTF, AMC, CFL, CFO, CAZ, CRO, CTX, CPM, NAL, NOR, ENO, CIP, SUT, GEN | CTX-M-2 group, qnrD |
| LB UEL – A05 | mrpA, ucaA, pmfA, atfA, ireA, ptA, zapA, hpmA | + | + | + | AMP, CTF, AMC, CFL, CAZ, CRO, CTX, NAL, ENO, CIP, SUT, ATM, GEN | qnrD |
| LB UEL – A06 | mrpA, ucaA, pmfA, atfA, ireA, ptA, zapA, hpmA | + | + | + | AMP, NAL, NOR, ENO, CIP, SUT, GEN | qnrD |
| LB UEL – A07 | mrpA, ucaA, pmfA, atfA, ireA, ptA, zapA, hpmA | + | + | + | AMP, AMC, CFL, NAL, NOR, ENO, CIP, SUT, ATM, GEN | qnrD |
| LB UEL – A08 | mrpA, pmfA, atfA, ireA, ptA, zapA, hpmA | + | + | + | AMP, CTF, AMC, CFL, CFO, CAZ, CRO, CTX | CIT |
| LB UEL – A09 | mrpA, pmfA, atfA, ireA, ptA, zapA, hpmA | + | + | + | AMP, CTF, AMC, CFL, CFO, CRO, CTX, CPM, NAL, ENO, SUT, ATM, CLO | CTX-M-2 group, CIT, qnrD |
| LB UEL – A10 | mrpA, pmfA, atfA, ireA, ptA, zapA, hpmA | + | − | + | AMP, CTF, AMC, CFL, CFO, CRO, CTX, CPM, NAL, NOR, ENO, CIP, SUT | CTX-M-2 group, qnrD |
| LB UEL – A11 | mrpA, pmfA, atfA, ireA, ptA, zapA, hpmA | + | + | + | AMP, CTF, CFL, CFO, CRO, CTX, CPM, NAL, NOR, ENO, CIP, SUT | CTX-M-2 group, qnrD |
| LB UEL – A12 | mrpA, ucaA, pmfA, atfA, ireA, ptA, zapA, hpmA | + | + | + | CFL, NAL, SUT | Not found |
| LB UEL – A13 | mrpA, pmfA, atfA, ireA, ptA, zapA, hpmA | + | − | + | AMP, AMC, CTF, CFL, CFO, CAZ, CRO, CTX, NAL, ENO, SUT, GEN | CIT, qnrD |
| LB UEL – A14 | mrpA, ucaA, pmfA, atfA, ireA, ptA, zapA, hpmA | + | + | + | CFL | Not found |
| LB UEL – A15 | mrpA, pmfA, atfA, ireA, ptA, zapA, hpmA | + | + | + | AMP, AMC, CTF, CFL, CFO, CAZ, CRO, CTX, NAL, ENO, SUT, CLO, GEN | CIT, qnrD |
| LB UEL – A16 | mrpA, pmfA, atfA, ireA, ptA, zapA, hpmA | + | + | + | AMP, AMC, CFL, CFO, CAZ, CRO, CTX, NAL, NOR, ENO, CIP, SUT, GEN, AMI | CIT, qnrD |
| LB UEL – A17 | mrpA, ucaA, pmfA, atfA, ireA, ptA, zapA, hpmA | + | + | + | AMC, CFL, CFO, CAZ, CTX, CPM, NAL, ATM | CTX-M-2 group |
| LB UEL – A18 | mrpA, ucaA, pmfA, atfA, ireA, ptA, zapA, hpmA, | + | + | + | AMP, CTF, AMC, CFL, CRO, CTX, CPM, NAL, ENO, CIP, SUT, GEN | CTX-M-2 group, qnrD |
| LB UEL – A19 | mrpA, ucaA, pmfA, atfA, ireA, ptA, zapA, hpmA | + | + | + | Not found | Not found |
| LB UEL – A20 | mrpA, ucaA, pmfA, atfA, ireA, ptA, zapA, hpmA | + | + | + | AMP, NAL, NOR, ENO, CIP, SUT, GEN | qnrD |
| LB UEL – A21 | mrpA, ucaA, pmfA, atfA, ireA, ptA, zapA, hpmA | + | + | + | AMP, CFL, NAL, NOR, ENO, CIP, SUT, CLO, GEN | qnrD |
| LB UEL – A22 | mrpA, pmfA, atfA, ireA, ptA, zapA, hpmA | + | + | + | AMP, CTF, AMC, CFL, CFO, CAZ, CRO, CTX, CPM, NAL, NOR, ENO, CIP, SUT, ATM | CTX-M-2 group, CIT, qnrD |
| LB UEL – A23 | mrpA, ucaA, pmfA, atfA, ireA, ptA, zapA, hpmA | + | − | + | NAL, ENO | qnrD |
| LB UEL – A24 | mrpA, ucaA, pmfA, atfA, ireA, ptA, zapA, hpmA | + | + | + | AMP, CFL, NAL, NOR, ENO, CIP, SUT, GEN | qnrD |
| LB UEL – A25 | mrpA, pmfA, atfA, ireA, ptA, zapA, hpmA | + | + | + | AMP, CTF, AMC, CFL, CFO, CAZ, CRO, CTX, NAL, ENO, SUT, CLO, GEN | CIT, qnrD |
| LB UEL – A26 | mrpA, ucaA, pmfA, atfA, ireA, ptA, zapA, hpmA | + | + | + | AMP, CFL, CFO, NAL, NOR, ENO, CIP, SUT, GEN | qnrD |
| LB UEL – A27 | mrpA, pmfA, atfA, ireA, ptA, zapA, hpmA | + | + | + | AMP, AMC, CFL, CFO, CAZ, CRO, CTX, NAL, ENO, SUT, GEN | CIT, qnrD |
| LB UEL – A28 | mrpA, pmfA, atfA, ireA, ptA, zapA, hpmA | + | + | + | CTF, AMC, CFL, CFO, NAL, SUT, GEN, AMI | Not found |
| LB UEL – A29 | mrpA, pmfA, atfA, ireA, ptA, zapA, hpmA | + | + | + | NAL, ENO, CIP | qnrD |
| LB UEL – A30 | mrpA, pmfA, atfA, ireA, ptA, zapA, hpmA | + | + | + | AMP, CTF, AMC, CFL, CFO, CRO, CTX, CPM, NAL, GEN | CTX-M-2 group |
| LB UEL – A31 | mrpA, ucaA, pmfA, atfA, ireA, ptA, zapA, hpmA | + | + | + | CFL, CFO, NAL, ENO | qnrD |
| LB UEL – A32 | mrpA, ucaA, pmfA, atfA, ireA, ptA, zapA, hpmA | + | + | + | AMP, AMC, CFL, CFO, NAL, SUT, GEN | Not found |
A.A, aggregative adhesion; C.V.C, cytotoxicity in vero cells; AMP, ampicillin; CTF, ceftiofur; AMC, amoxicillin-clavulanic acid; CFL, cephalotin; CFO, cefoxitin; CAZ, ceftazidime; CRO, ceftriaxone; CTX, cefotaxime; CPM, cefepime; NAL, nalidixic acid; NOR, norfloxacin; ENO, enrofloxacin; CIP, ciprofloxacin; SUT, trimethoprim-sulfamethoxazole; ATM, aztreonam; CLO, chloramphenicol; GEN, gentamicin; AMI, amikacin. + positive; − negative
Genotypic and phenotypic profile of resistance to antimicrobials
Twenty antimicrobials belonging to several classes were tested. Resistance profiles of isolates ranged of strains susceptible to all antimicrobials tested to strains resistant to 15 different antimicrobials. Of all the antimicrobials tested, the isolates presented a higher frequency of resistance (> 50%) to ampicillin, amoxicillin-clavulanic acid, cefotaxime, nalidixic acid, enrofloxacin, trimethoprim-sulfamethoxazole, and gentamicin. The isolates showed greater susceptibility to the antimicrobials aztreonam, chloramphenicol, amikacin, ertapenem, and imipenem, highlighting the last two in which none of the isolates presented resistance. The frequency of antimicrobial resistance of the isolates is shown in Fig. 3. Of all the strains, 25 (78.13%) were MDR, being resistant to three or more classes of antimicrobials.
Fig. 3.
Frequency of antimicrobial resistance of P. mirabilis isolated from chicken carcasses
In relation to the blaESBL and AmpC genes responsible for conferring resistance to β-lactam antimicrobials, eight (25%) isolated had the CTX-M-2 group, while 11 (34.38%) had only the CIT group. The plasmidial gene qnrD that confers resistance to quinolones was found in 23 (71.88%) isolates, demonstrating the high prevalence of this gene in P. mirabilis isolated from chicken carcasses. The CTX-M-2 and CIT groups were found together in two isolates, CIT and qnrD in nine, qnrD and CTX-M-2 in four isolates. The CTX-M-2, CIT, and qnrD groups were found together in two strains. (Table 2).
Discussion
The bacterial isolates studied presented a variety of virulence genes that enable and contribute to the development of infection. Our results evidenced a variety of genes responsible for encoding fimbriae (Table 2) that contribute to the UTI in humans, such as fimbriae MR/P, PMF, and UCA [39, 40]. A study conducted by Barbour et al. [41] detected the mrpA gene in all strains of P. mirabilis isolated from chicken and human and identified a high nucleotide similarity between them, suggesting a possible zoonotic potential of these strains. The ambient temperature fimbriae (ATF) do not contribute to UTI, but its expression may allow the permanence of P. mirabilis in the environment [21].
Besides fimbrial genes, a high prevalence of genes zapA, ptA (proteases), hpmA (hemolysin), and ireA (siderophores receptor) was also found in our isolates (Table 2), evidencing that chicken carcasses may contain P. mirabilis with a diversity of virulence genes. In relation to the genes coding hemolysins, all isolates had hpmA, whereas hlyA was not detected in any of these. These findings are in agreement with other studies, which report a higher prevalence of hpmA than hlyA in P. mirabilis [12, 42]. Few studies involving research on virulence factors in P. mirabilis strains of food and infections are reported. This is the first study that shows evidence for the presence of the virulence genes pmfA, ucaA, atfA, hpmA, zapA, ptA, and ireA in P. mirabilis isolated from chicken carcasses.
We have observed that most of the virulence factors investigated are related to an extraintestinal pathogenic profile, such as the extraintestinal pathogenic Escherichia coli (ExPEC). This clue may be supported by the fact that our isolates possessed a diversity of virulence factors that are commonly found in ExPEC, such as fimbriae, hemolysins, proteases, and the iron uptake system [43–45]. Other studies also report a high prevalence of virulence factors in E. coli isolated from chicken carcasses and highlight the pathogenic potential of these strains in developing extraintestinal infections in humans [46, 47]. This hypothesis is strongly supported by other works [48–50], as well as a study conducted by Vincent et al. [51], which reports an intimate similarity between strains of E. coli isolated from chicken meat and UTIs.
We believe that chicken meat can be contaminated with P. mirabilis in the slaughter line during the carcass evisceration process or by cross contamination. It is also believed that these strains can be transmitted to consumers, colonize the human intestinal tract, and possibly develop extraintestinal infections, such as UTIs, similarly to what it is believed to occur with E. coli from food sources [48–51].
The colonization of the epithelium is important for P. mirabilis uropathogenicity. This ability can be demonstrated by experiments using different cell lines [52]. The aggregative adherence pattern has been previously reported in uropathogenic P. mirabilis [20]. It is known that the expression of the MR\P fimbriae contributes to this adhesion pattern [20]. This evidence supports our results since all the isolates had the mrpA gene and expressed the aggregative adherence pattern. This is the first report of P. mirabilis isolated from chicken carcasses expressing the aggregative adherence pattern in HEp-2 cells. This pattern of adhesion has also been demonstrated in E. coli isolated from extraintestinal infections [43, 45].
The cytotoxic effect is also considered important in the infectious process, especially in uropathogenecity, and was exhibited by most of our isolates (84.38%). There is evidence that the hemolysin HpmA is responsible for most of the cytotoxicity in renal cell lines since the isogenic mutant strains for this virulence factor were significantly less cytotoxic than the wild type strains [53]. Despite all of our isolates have possessed the hpmA gene, some of them have not expressed cytotoxic effect in Vero cells which may be due to the non-expression of this gene in vitro. However, their expression may occur in vivo and contribute to the infectious process.
Foodborne biofilm-forming bacteria pose serious risks to human health and have become increasingly frequent in the food industry, opportunizing the dissemination of biofilm-forming strains, mainly through cross-contamination [54, 55]. Our results are alarming, considering that all the strains isolated from chicken carcasses in a slaughterhouse in the north of Paraná formed a strong or very strong biofilm. In the host, biofilm formation protects bacteria from the immune system and antimicrobials, as well as contribute to the persistence of infection [56]. Biofilms in P. mirabilis are well studied, they are mainly associated with urinary catheters, which can block urinary flow and cause ascending infection, pyelonephritis, and possible sepsis [57]. It is important to note that some of our isolates, such as the strain LB UEL - A07, expressed a biofilm at the intensity similar to the positive control EAEC 042, a diarrheagenic E. coli very well known to form a very strong biofilm [25] (Fig. 2).
The isolation of bacteria that pose a threat to the health of the consumer becomes more aggravating when these, besides having factors of virulence, also present resistance to the antimicrobials, mainly when these are used for the treatment of infections in humans [58]. Our results in Fig. 3 show, that even though many antimicrobials are prohibited on poultry farms, a high frequency of P. mirabilis MDR was found, in which 25 (78.13%) isolates were resistant to three or more classes of antimicrobials [33].
The presence of MDR P. mirabilis and producers of ESBLs isolated from chicken meat has been reported in a few studies [6, 59]. The high prevalence of CTX-M-2 and CIT groups has been reported in E. coli isolated from chicken carcasses in Paraná, Brazil [46]. In addition, a study in the UK reported the detection of the CTX-M-2 group in E. coli isolated from chicken meat imported from Brazil [60]. Our study evidenced a high prevalence of the qnrD gene in P. mirabilis isolated from chicken carcasses, which has been commonly found in genera of the Proteeae tribe, such as Proteus, Providencia, and Morganella [61].
It is important to highlight the considerable rate of resistance to quinolones and cephalosporins of the third and fourth generation found in this study (Fig. 3), since these antimicrobials are frequently used in the treatment of human infections [62, 63]. Similar results were also found in a study in China [6]. Currently, a variety of human infectious diseases are currently treated with quinolones, including abdominal infections, chronic bronchitis, community-acquired pneumonia, nosocomial infections, sexually transmitted infections, skin infections, and urinary tract infections [62]. This is the first report of groups CTX-M-2, CIT, and qnrD in P. mirabilis isolated from chicken carcasses in Brazil.
Therefore, chicken meat can be a source of transmission and dissemination of P. mirabilis strains resistant to antimicrobials and carriers plasmid-mediated resistance genes to the community. Thus, it is essential that chicken producers are cautious about the prophylactic use of antimicrobial agents in poultry production, mainly as a food additive [8]. The study of resistant bacteria and plasmid-mediated resistance is important mainly because infections caused by resistant strains are more related to high morbidity and mortality rates than susceptible strains [64].
In the present study, it was demonstrated that chicken carcasses of a slaughterhouse in the north of Paraná are a potential risk for consumer health. As shown in Table 2, they carried P. mirabilis strains with a great diversity of virulence factors and antimicrobial resistance determinants, both phenotypically and genotypically. These findings become more aggravating when we consider the possibility of these strains colonizing the intestinal tract of the consumers and horizontally transfer the plasmid genes associated with antimicrobial resistance to the commensal strains. Our results are alarming, since the state of Paraná is responsible for most of the chicken meat exports from Brazil [1].
Although few reports, P. mirabilis has been associated with an outbreak of gastroenteritis and vomiting in a study that found the identical P. mirabilis strain in a diarrheic stool sample and vomit of a patient affected with food poisoning [17]. These associations were strongly sustained during an outbreak caused by the consumption of pork cooked in China, in which an identical strain was isolated from the hospitalized individuals, kitchen handler, waiter, and contaminated food waste, proving the clonal relation of the strains by Pulsed-field gel electrophoresis (PFGE) [16]. However, more studies need to be done to elucidate whether P. mirabilis can be considered the primary pathogen of food poisoning and which virulence factors contribute to it.
In addition, P. mirabilis has also been associated with pneumonia [65] and sepsis and infection of the central nervous system [66]. Therefore, the high frequency of P. mirabilis recovered from chicken carcasses in our study is alarming, considering that chicken meat may be responsible for disseminating P. mirabilis with virulence potential and MDR via the food chain.
Conclusions
In conclusion, P. mirabilis isolated from chicken carcasses have a variety of virulence factors and are resistant to multiple antimicrobials used in the treatment of human infections. Therefore, it is important that the consumer is aware of the risk when handling and preparing chicken meat, as well as performing a correct disinfection of the kitchen tools after the preparation of this meat, in order to avoid contact, cross-contamination, and possible food poisoning with this pathogen. In addition, we believe that the major risk is the colonization of the intestinal tract by these strains and further the development of extraintestinal diseases, such as UTIs.
Acknowledgments
The authors are thankful to the Laboratory of Virology of State University of Londrina for providing the HEp-2 cells.
Funding
This study was financed by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior Brasil (CAPES) - Finance Code 001.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflicts of interest.
Footnotes
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.ABPA (2017) Brazilian association of animal protein. Annual Report. http://abpa-br.com.br/storage/files/final_abpa_relatorio_anual_2017_ingles_web.pdf. Accessed 10 March 2019
- 2.Rouger A, Tresse O, Zagorec M. Bacterial contaminants of poultry meat: sources, species, and dynamics. Microorg. 2017;5(3):1–16. doi: 10.3390/microorganisms5030050. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Drzewiecka D. Significance and roles of Proteus spp. Bacteria in natural environments. Microb Ecol. 2016;72(4):741–758. doi: 10.1007/s00248-015-0720-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Firildak G, Asan A, Goren E. Chicken carcasses bacterial concentration at poultry slaughtering facilities. Asian J Biol Sci. 2015;8(1):16–29. doi: 10.3923/ajbs.2015.16.29. [DOI] [Google Scholar]
- 5.Kim SH, Wei CI, An H. Molecular characterization of multidrug-resistant Proteus mirabilis isolates from retail meat products. J Food Prot. 2005;68(7):1408–1413. doi: 10.4315/0362-028X-68.7.1408. [DOI] [PubMed] [Google Scholar]
- 6.Wong MH, Wan HY, Chen S. Characterization of multidrug-resistant Proteus mirabilis isolated from chicken carcasses. Foodborne Pathog Dis. 2013;10(2):177–181. doi: 10.1089/fpd.2012.1303. [DOI] [PubMed] [Google Scholar]
- 7.Boeckel TPV, Brower C, Gilbert M, et al. Global trends in antimicrobial use in food animals. Proc Natl Acad Sci. 2015;112(18):5649–5654. doi: 10.1073/pnas.1503141112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Nhung NT, Chansiripornchai N, Carrique-mas JJ. Antimicrobial resistance in bacterial poultry pathogens: a review. Front Vet Sci. 2017;4:1–17. doi: 10.3389/fvets.2017.00126. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Armbruster CE, Mobley HLT, Pearson MM. Pathogenesis of Proteus mirabilis infection. EcoSal Plus. 2018;8(1):1–123. doi: 10.1128/ecosalplus.ESP-0009-2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Alamuri P, Eaton KA, Himpsl SD, Smith SN, Mobley HLT. Vaccination with proteus toxic agglutinin, a hemolysin-independent cytotoxin in vivo, protects against Proteus mirabilis urinary tract infection. Infect Immun. 2009;77(2):632–641. doi: 10.1128/IAI.01050-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Belas R, Manos J, Suvanasuthi R. Proteus mirabilis ZapA metalloprotease degrades a broad spectrum of substrates, including antimicrobial peptides. Infect Immun. 2004;72(9):5159–5167. doi: 10.1128/IAI.72.9.5159-5167.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Cestari SE, Ludovico MS, Martins FH, da Rocha SPD, Elias WP, Pelayo JS. Molecular detection of HpmA and HlyA hemolysin of uropathogenic Proteus mirabilis. Curr Microbiol. 2013;67(6):703–707. doi: 10.1007/s00284-013-0423-5. [DOI] [PubMed] [Google Scholar]
- 13.Mobley HLT, Chippendale GR. Hemagglutinin, urease, and hemolysin production by Proteus mirabilis from clinical sources. J Infect Dis. 1990;161(3):525–530. doi: 10.1093/infdis/161.3.525. [DOI] [PubMed] [Google Scholar]
- 14.Himpsl SD, Pearson MM, Arewång CJ, Nusca TD, Sherman DH, Mobley HL. Proteobactin and a yersiniabactin-related siderophore mediate iron acquisition in Proteus mirabilis. Mol Microbiol. 2010;78(1):138–157. doi: 10.1111/j.1365-2958.2010.07317.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Schaffer JN, Pearson MM. Proteus mirabilis and urinary tract infections. Microbiol Spectr. 2015;3(5):1–39. doi: 10.1128/microbiolspec.UTI-0017-2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Wang Y, Zhang S, Yu J, Zhang H, Yuan Z, Sun Y, Zhang L, Zhu Y, Song H. An outbreak of Proteus mirabilis food poisoning associated with eating stewed pork balls in brown sauce, Beijing. Food Control. 2010;21(3):302–305. doi: 10.1016/j.foodcont.2009.06.009. [DOI] [Google Scholar]
- 17.Shi X, Lin Y, Qiu Y, et al. Comparative screening of digestion tract toxic genes in Proteus mirabilis. PLoS One. 2016;11(3):1–12. doi: 10.1371/journal.pone.0151873. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Wu Y, Liu X, Chen Q, Liu H, Dai Y, Zhou YJ, Wen J, Tang ZZ, Chen Y. Surveillance for foodborne disease outbreaks in China, 2003 to 2008. Food Control. 2018;84:382–388. doi: 10.1016/j.foodcont.2017.08.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Hamilton AL, Kamm MA, Ng SC, et al. Proteus spp. as putative gastrointestinal pathogens. Clin Microbiol Rev. 2018;31(3):1–19. doi: 10.1128/CMR.00085-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Rocha SPD, Elias WP, Cianciarullo AM, et al. Aggregative adherence of uropathogenic Proteus mirabilis to cultured epithelial cells. FEMS Immunol Med Microbiol. 2007;51(2):319–326. doi: 10.1111/j.1574-695X.2007.00308.x. [DOI] [PubMed] [Google Scholar]
- 21.Zunino P, Geymonat L, Allen AG, Legnani-Fajardo C, Maskell DJ. Virulence of a Proteus mirabilis ATF isogenic mutant is not impaired in a mouse model of ascending urinary tract infection. FEMS Immunol Med Microbiol. 2000;29(2):137–143. doi: 10.1111/j.1574-695X.2000.tb01516.x. [DOI] [PubMed] [Google Scholar]
- 22.Pearson MM, Sebaihia M, Churcher C, Quail MA, Seshasayee AS, Luscombe NM, Abdellah Z, Arrosmith C, Atkin B, Chillingworth T, Hauser H, Jagels K, Moule S, Mungall K, Norbertczak H, Rabbinowitsch E, Walker D, Whithead S, Thomson NR, Rather PN, Parkhill J, Mobley HLT. Complete genome sequence of uropathogenic Proteus mirabilis, a master of both adherence and motility. J Bacteriol. 2008;190(11):4027–4037. doi: 10.1128/JB.01981-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Cravioto A, Gross RJ, Scotland SM, Rowe B. An adhesive factor found in strains of Escherichia coli belonging to the traditional infantile enteropathogenic serotypes. Curr Microbiol. 1979;3(2):95–99. doi: 10.1007/BF02602439. [DOI] [Google Scholar]
- 24.Levine MM, Bergquist EJ, Nalin DR, Waterman DH, Hornick RB, Young CR, Sotman S. Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive. Lancet. 1978;1:1119–1122. doi: 10.1016/S0140-6736(78)90299-4. [DOI] [PubMed] [Google Scholar]
- 25.Nataro JP, Yikang D, Cookson S, Cravioto A, Savarino SJ, Guers LD, Levine MM, Tacket CO. Heterogeneity of enteroaggregative Escherichia coli virulence demonstrated in Volunteers. J Infect Dis. 1995;171(2):465–468. doi: 10.1093/infdis/171.2.465. [DOI] [PubMed] [Google Scholar]
- 26.Bilge SS, Clausen CR, Lau WE. Molecular characterization of a fimbrial adhesin, F1845, mediating diffuse adherence of diarrhea-associated Escherichia coli to HEp-2 cells. J Bacteriol. 1989;171(8):4281–4289. doi: 10.1128/jb.171.8.4281-4289.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Konowalchuk J, Speirs JL, Stavric S. Vero response to a cytotoxin of Escherichia coli. Infect Immun. 1977;18(3):775–779. doi: 10.1128/iai.18.3.775-779.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Murakami J, Kishi K, Hirai K, Hiramatsu K, Yamasaki T, Nasu M. Macrolides and clindamycin suppress the release of Shiga-like toxins from Escherichia coli O157:H7 in vitro. Int J Antimicrob Agents. 2000;15(2):103–109. doi: 10.1016/S0924-8579(00)00126-6. [DOI] [PubMed] [Google Scholar]
- 29.Yu J, Kaper JB. Cloning and characterization of the eae gene of enterohemorragic Escherichia coli O157:H7. Mol Microbiol. 1992;6(3):411–417. doi: 10.1111/j.1365-2958.1992.tb01484.x. [DOI] [PubMed] [Google Scholar]
- 30.Kwiecinska-Piróg J, Bogiel T, Skowron K, Wieckowska E, Gospodarek E. Proteus mirabilis biofilm - qualitative and quantitative colorimetric methods-based evaluation. Braz J Microbiol. 2014;45(4):1423–1431. doi: 10.1590/S1517-83822014000400037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Clinical and Laboratory Standards Institute (CLSI) (2018) Performance standards for antimicrobial susceptibility testing. 28th edn. CLSI supplement M100. Wayne
- 32.Clinical and Laboratory Standards Institute (CLSI) (2008) Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals. 3rd edn. CLSI Document M31-A3. Wayne
- 33.Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi: 10.1111/j.1469-0691.2011.03570.x. [DOI] [PubMed] [Google Scholar]
- 34.Woodford N, Fagan EJ, Ellington MJ. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum β-lactamases. J Antimicrob Chemother. 2006;57(1):154–155. doi: 10.1093/jac/dki412. [DOI] [PubMed] [Google Scholar]
- 35.Arlet G, Philippon A. Construction by polymerase chain reaction and use of intragenic DNA probes for three main types of transferable beta-lactamase (TEM, SHV, CARB) FEMS Microbiol Lett. 1991;66(1):19–25. doi: 10.1016/0378-1097(91)90414-6. [DOI] [PubMed] [Google Scholar]
- 36.Pérez-pérez FJ, Hanson ND. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol. 2002;40(6):2153–2162. doi: 10.1128/JCM.40.6.2153-2162.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Cattoir V, Poirel L, Rotimi V, Soussy CJ, Nordmann P. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother. 2007;60(2):394–397. doi: 10.1093/jac/dkm204. [DOI] [PubMed] [Google Scholar]
- 38.Cavaco LM, Hasman H, Xia S, Aarestrup FM. qnrD, a novel gene conferring transferable quinolone resistance in Salmonella entérica Serovar Kentucky and Bovismorbificans strains of human origin. Antimicrob Agents Chemother. 2009;53(2):603–608. doi: 10.1128/AAC.00997-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Zunino P, Sosa V, Schlapp G, Allen AG, Preston A, Maskell DJ. Mannose-resistant Proteus-like and P. mirabilis fimbriae have specific and additive roles in P. mirabilis urinary tract infections. FEMS Immunol Med Microbiol. 2007;51(1):125–133. doi: 10.1111/j.1574-695X.2007.00285.x. [DOI] [PubMed] [Google Scholar]
- 40.Pellegrino R, Scavoane P, Umpiérrez A, et al. Proteus mirabilis uroepithelial cell adhesin (UCA) fimbria plays a role in the colonization of the urinary tract. Pathog Dis. 2013;67(2):104–107. doi: 10.1111/2049-632X.12027. [DOI] [PubMed] [Google Scholar]
- 41.Barbour EK, Hajj ZG, Hamadeh S, Shaib HA, Farran MT, Araj G, Faroon O, Barbour KE, Jirjis F, Azhar E, Kumosani T, Harakeh S. Comparison of phenotypic and virulence genes characteristics in human and chicken isolates of Proteus mirabilis. Pathog Glob Health. 2012;106(6):352–357. doi: 10.1179/2047773212Y.0000000042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Swihart KG, Welch RA. The Hpma hemolysin is more common than Hlya among Proteus isolates. Infect Immun. 1990;58(6):1853–1860. doi: 10.1128/iai.58.6.1853-1860.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Toval F, Köhler CD, Vogel U, et al. Characterization of Escherichia coli isolates from hospital inpatients or outpatients with urinary tract infection. J Clin Microbiol. 2014;52(2):407–418. doi: 10.1128/JCM.02069-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Cyoia PS, Rodrigues GR, Nishio EK, Medeiros LP, Koga VL, Pereira APD, Vespero EC, Houle S, Dozois CM, Nakazato G, Kobayashi RKT. Presence of virulence genes and pathogenicity islands in extraintestinal pathogenic Escherichia coliisolates from Brazil. J Infect Dev Ctries. 2015;9(10):1068–1075. doi: 10.3855/jidc.6683. [DOI] [PubMed] [Google Scholar]
- 45.Cergole-Novella MC, Pignatari ACC, Guth BEC. Adhesion, biofilm and genotypic characteristics of antimicrobial resistant Escherichia coli isolates. Braz J Microbiol. 2015;46(1):167–171. doi: 10.1590/S1517-838246120140077. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Koga VL, Scandorieiro S, Vespero EC, Oba A, de Brito BG, de Brito KCT, Nakazato G, Kobayashi RKT. Comparison of antibiotic resistance and virulence factors among Escherichia coli isolated from conventional and free-range poultry. Biomed Res Int. 2015;2015:1–8. doi: 10.1155/2015/618752. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Cyoia PS, Koga VL, Nishio EK, et al. Distribution of ExPEC virulence factors, blaCTX-M, fosA3, and mcr-1 in Escherichia coli isolated from commercialized chicken carcasses. Front Microbiol. 2019;9:1–9. doi: 10.3389/fmicb.2018.03254. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Manges AR, Smith SP, Lau BJ, Nuval CJ, Eisenberg JNS, Dietrich PS, Riley LW. Retail meat consumption and the acquisition of antimicrobial resistant Escherichia coli causing urinary tract infections: a case-control study. Foodborne Pathog Dis. 2007;4(4):419–431. doi: 10.1089/fpd.2007.0026. [DOI] [PubMed] [Google Scholar]
- 49.Manges AR, Johnson JR. Food-borne origins of Escherichia coli causing extraintestinal infections. Clin Infect Dis. 2012;55(5):712–719. doi: 10.1093/cid/cis502. [DOI] [PubMed] [Google Scholar]
- 50.Manges AR. Escherichia coli and urinary tract infections: the role of poultry-meat. Clin Microbiol Infect. 2016;22(2):122–129. doi: 10.1016/j.cmi.2015.11.010. [DOI] [PubMed] [Google Scholar]
- 51.Vincent C, Boerlin P, Daignault D, Dozois CM, Dutil L, Galanakis C, Reid-Smith RJ, Tellier PP, Tellis PA, Ziebell K, Manges AR. Food reservoir for Escherichia coli causing urinary tract infections. Emerg Infect Dis. 2010;16(1):88–95. doi: 10.3201/eid1601.091118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Rózalski A, Sidorczyk Z, Kotelko K. Potential virulence factors of Proteus bacilli. Microbiol Mol Biol Rev. 1997;61(1):65–89. doi: 10.1128/mmbr.61.1.65-89.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Mobley HLT, Chippendale GR, Swihart KG, Welch RA. Cytotoxicity of the HpmA hemolysin and urease of Proteus mirabilis and Proteus vulgaris against cultured human renal proximal tubular epithelial cells. Infect Immun. 1991;59(6):2036–2042. doi: 10.1128/iai.59.6.2036-2042.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Zhao X, Zhao F, Wang J, Zhong N. Biofilm formation and control strategies of foodborne pathogens: food safety perspectives. RSC Adv. 2017;7(58):36670–36683. doi: 10.1039/C7RA02497E. [DOI] [Google Scholar]
- 55.Galié S, García-gutiérrez C, Miguélez EM, et al. Biofilms in the food industry: health aspects and control methods. Front Microbiol. 2018;9:1–18. doi: 10.3389/fmicb.2018.00898. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Kostakioti M, Hadjifrangiskou M, Hultgren SJ. Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era. Cold Spring Harb Perspect Med. 2013;3(4):1–23. doi: 10.1101/cshperspect.a010306. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Armbruster CE, Mobley HLT. Merging mythology and morphology: the multifaceted lifestyle of Proteus mirabilis. Nat Rev Microbiol. 2012;10(11):743–754. doi: 10.1038/nrmicro2890. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Marshall BM, Levy SB. Food animals and antimicrobials: impacts on human health. Clin Microbiol Rev. 2011;24(4):718–733. doi: 10.1128/CMR.00002-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Shrestha A, Bajracharya AM, Subedi H, et al. Multi-drug resistance and extended spectrum beta lactamase producing gram negative bacteria from chicken meat in Bharatpur Metropolitan, Nepal. BMC Res Notes. 2017;10(1):1–5. doi: 10.1186/s13104-016-2345-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Warren RE, Ensor VM, O’Neill P, et al. Imported chicken meat as a potential source of quinolone-resistant Escherichia coli producing extended-spectrum β-lactamases in the UK. J Antimicrob Chemother. 2008;61(3):504–508. doi: 10.1093/jac/dkm517. [DOI] [PubMed] [Google Scholar]
- 61.Kraychete GB, Campana EH, Picão RC, Bonelli RR. qnrD-harboring plasmids in Providencia spp. recovered from food and environmental Brazilian sources. Sci Total Environ. 2019;646:1290–1292. doi: 10.1016/j.scitotenv.2018.07.378. [DOI] [PubMed] [Google Scholar]
- 62.Aldred KJ, Kerns RJ, Osheroff N. Mechanism of quinolone action and resistance. Biochem. 2014;53(10):1565–1574. doi: 10.1021/bi5000564. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Rahman SU, Ali T, Ali I, et al. The growing genetic and functional diversity of extended spectrum beta-lactamases. Biomed Res Int. 2018;2018:1–14. doi: 10.1155/2018/9519718. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Gopinathan A, Mukhopadhyay C, Vandana KE. Characterization of antimicrobial resistance mechanisms of multidrug resistant gram negative bacterial wound infections and their clinical epidemiology from a tertiary care hospital in Karnataka, India. Int J Res Med Sci. 2017;5(3):824–828. doi: 10.18203/2320-6012.ijrms20170535. [DOI] [Google Scholar]
- 65.Okimoto N, Hayashi T, Ishiga M, Nanba F, Kishimoto M, Yagi S, Kurihara T, Asaoka N, Tamada S. Clinical features of Proteus mirabilis pneumonia. J Infect Chemother. 2010;16(5):364–366. doi: 10.1007/s10156-010-0059-3. [DOI] [PubMed] [Google Scholar]
- 66.Kassim Z, Aziz AA, Haque QM, Cheung HAS. Isolation of Proteus mirabilis from severe neonatal sepsis and central nervous system infection with extensive pneumocephalus. Eur J Pediatr. 2003;162(9):644–645. doi: 10.1007/s00431-003-1240-9. [DOI] [PubMed] [Google Scholar]


